Global Parkinson’s Genetics Program Intellectual Property Policy

Version October 2020

In support of the Aligning Science Across Parkinson’s (ASAP) strategic objectives of supporting collaboration, generating resources, and democratizing access to data, the Global Parkinson’s Genetics Program (GP2) has been established as a pre-competitive consortium. GP2’s intellectual property (IP) policy is briefly summarized below:

1. Rights to existing IP that is used to interrogate GP2 data remain with the inventor. GP2 will not ‘reach through’ to any background IP. For example, if you use a patented algorithm to interrogate GP2 data, GP2 will not attempt to claim any ownership of your previously existing algorithm.

2. Improvements to existing IP using GP2 data are allowed. For example, if you use a patented algorithm to interrogate GP2 data and, as a result, are able to refine the parameters of your algorithm, you may claim IP on this improvement to your algorithm.

3. No new IP may be generated using GP2 data. For example, if you create an algorithm using GP2 data, you may not claim IP on this new algorithm.

GP2 is committed to open science and to creating a foundational resource for the Parkinson’s disease research community. Further, the following points support the decision to prohibit the generation of new IP using GP2 data:

  • A rising tide lifts all boats. The need to better understand the genetic basis of Parkinson’s disease and to make the understanding of the genetic basis of Parkinson’s disease globally relevant is a field-wide challenge. Ensuring that any findings coming out of GP2 can be widely shared and leveraged advances the entire Parkinson’s disease research field. These challenges are too large and complex for any one group to tackle on its own.
  • Power in numbers. A pre-competitive environment encourages collaboration, results-sharing, and replication. Bringing together multiple stakeholders helps to avoid duplication of efforts, which leads to better prioritization of resources. GP2 encourages contributions of samples, data, and analyses from academic and industry groups and is committed to making data available to the entire research community as rapidly as possible. In addition, encouraging networking is a key component of GP2.
  • Every cohort counts. GP2 is possible because of the contributions of data and DNA from investigators and study sponsors that agree to join the collaboration. Many of these cohorts already have policies in place that do not allow IP generation. If GP2 data users could create a competitive advantage based on contributed data, cohorts would be disincentivized from contributing their materials.

Questions? Email [email protected]